WallStSmart
STXS

Stereotaxis Inc

NYSE MKT: STXS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$1.87
+2.75% today

Updated 2026-04-30

Market cap
$188.13M
P/E ratio
P/S ratio
5.81x
EPS (TTM)
$-0.25
Dividend yield
52W range
$2 – $4
Volume
0.4M

Stereotaxis Inc (STXS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-38.98M$-35.71M$-28.65M$-22.31M$-18.91M$-31.57M$-12.12M$-6.33M$-9.09M$-2.53M$-6.56M$-4.67M$-2.55M$-4.62M$-3.51M$-2.95M$-8.41M$-9.14M$-8.50M$-13.69M
Capital expenditures$2.31M$4.74M$1.67M$1.48M$715770.00$1.03M$130699.00$0.00$123912.00$153151.00$410184.00$81577.00$265482.00$29486.00$70896.00$1.40M$2.38M$366000.00$34000.00$93000.00
Depreciation
Stock-based comp$5.60B$2.99B$4.23M$2.05M$2.49M$2.29M$1.05M$1.50M$1.31M$1.37M$768682.00$560973.00$1.33M$3.17M$9.36M$10.58M$10.62M$10.26M$9.85M
Free cash flow$-41.29M$-40.46M$-30.32M$-23.79M$-19.63M$-32.60M$-12.25M$-6.33M$-9.22M$-2.68M$-6.97M$-4.76M$-2.81M$-4.65M$-3.58M$-4.34M$-10.79M$-9.51M$-8.53M$-13.78M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$-21.29M$-6.18M$6.00M$-6.50M$-1.68M$2.91M$-4.82M$7.11M$19.39M$13.76M$-3.80M$-30.29M